STERIS (NYSE:STE) Vs. ABT, MDT, ISRG, SYK, BDX, EW, BSX, IDXX, DXCM, and BAX
Should you be buying STERIS stock or one of its competitors? The main competitors of STERIS include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Stryker (SYK), Becton, Dickinson and (BDX), Edwards Lifesciences (EW), Boston Scientific (BSX), IDEXX Laboratories (IDXX), DexCom (DXCM), and Baxter International (BAX). These companies are all part of the "health care equipment" industry.
STERIS vs.
STERIS (NYSE:STE) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, community ranking, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.
Medtronic received 1256 more outperform votes than STERIS when rated by MarketBeat users. Likewise, 79.06% of users gave Medtronic an outperform vote while only 60.04% of users gave STERIS an outperform vote.
89.2% of STERIS shares are owned by institutional investors. Comparatively, 79.0% of Medtronic shares are owned by institutional investors. 1.1% of STERIS shares are owned by company insiders. Comparatively, 0.5% of Medtronic shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
STERIS presently has a consensus target price of $248.80, suggesting a potential upside of 6.09%. Medtronic has a consensus target price of $134.81, suggesting a potential upside of 24.19%. Given Medtronic's higher probable upside, analysts plainly believe Medtronic is more favorable than STERIS.
Medtronic has higher revenue and earnings than STERIS. Medtronic is trading at a lower price-to-earnings ratio than STERIS, indicating that it is currently the more affordable of the two stocks.
STERIS pays an annual dividend of $1.72 per share and has a dividend yield of 0.7%. Medtronic pays an annual dividend of $2.52 per share and has a dividend yield of 2.3%. STERIS pays out 61.4% of its earnings in the form of a dividend. Medtronic pays out 72.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
Medtronic has a net margin of 14.80% compared to STERIS's net margin of 6.50%. Medtronic's return on equity of 14.52% beat STERIS's return on equity.
STERIS has a beta of 0.64, meaning that its stock price is 36% less volatile than the S&P 500. Comparatively, Medtronic has a beta of 0.79, meaning that its stock price is 21% less volatile than the S&P 500.
In the previous week, Medtronic had 19 more articles in the media than STERIS. MarketBeat recorded 22 mentions for Medtronic and 3 mentions for STERIS. STERIS's average media sentiment score of 0.44 beat Medtronic's score of 0.35 indicating that STERIS is being referred to more favorably in the media.
Summary
Medtronic beats STERIS on 13 of the 20 factors compared between the two stocks.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding STE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment >-1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
STERIS (NYSE:STE) vs. Its Competitors
STERIS Competitors List
